Fergus Kennedy

Fergus Kennedy is a seasoned professional in product strategy and corporate development, currently serving as Principal of Product Strategy at Isomorphic Labs since August 2025, focusing on AI applications in science. Previously, Fergus held the role of Director of Corporate Development, Strategy & Operations at Resolution Therapeutics, where efforts concentrated on macrophage therapy for end-stage liver disease. Experience also includes a significant tenure at Eradigm Consulting as Principal, delivering strategy consulting services for the life sciences sector. Notable past roles include Global Cross-Portfolio Strategy Lead at Roche and Independent Business Consultant at Cambridge Enterprise, coupled with a research placement at AstraZeneca. Fergus earned a Master's Degree with Distinction in Bioscience Enterprise from the University of Cambridge and a First Class Bachelor's degree in Biological Sciences from the University of Oxford. Recognized for innovation, Fergus won the Healthcare Innovation category at the Telegraph STEM Awards 2016 for developing a drone-based vaccination system.